Renown Health inks data-tracking deal with BioIntelliSense
Dr. James Mault, founder and CEO of BioIntelliSense, holds the company's BioSticker device, which monitors data on a patient’s skin temperature, resting heart rate and respiratory rate, among other data.
Courtesy Photo
Renown Health this month announced it recently entered a partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company based in Denver.
The partnership integrates BioIntelliSense’s FDA-cleared wearable “BioSticker” device into Renown’s clinical remote monitoring services, according to a Dec. 6 press release, allowing for continuous remote monitoring for both in-hospital patient care as well as at-home health management. The company’s BioSticker monitors data on a patient’s skin temperature, resting heart rate and respiratory rate, step, gait, sleep, activity levels, and more, including infection-like symptom alerts that supports COVID-19 monitoring, according to the release. The BioSticker’s medical-grade trending and advanced analytics will be visualized and monitored by clinical staff within the Renown Transfer and Operations Center, which launched in August in South Reno. “Given the growing healthcare workforce crisis, routine patient monitoring has become more expensive and less frequent, especially during the ongoing public health emergency. With the BioSticker, vital signs monitoring can be provided for each patient far more frequently and at a fraction of the cost,” Dr. James Mault, founder and CEO of BioIntelliSense, said in a statement. “Our strategic partnership with Renown Health serves as a gold standard demonstration project for other hospital systems. What we are learning from patients and providers at Renown will help create fully integrated, continuous care delivery that starts during the patient’s hospitalization enabling monitoring of their health status throughout their recovery process, and from the comfort of their own home after leaving the hospital.” During the first phase of the collaboration, the BioSticker will be applied to all patients admitted to Renown South Meadows Medical Center, according to the press release; patients may wear the device throughout their hospital stay and continue to wear it when they leave for their homes, ambulatory, outpatient surgical, rehabilitation or skilled nursing settings. “We are excited to continue to enhance our relationships with patients by integrating technology that supplements our care teams and provides patients with a virtual care solution that will continuously track vital signs, making healthcare more accessible, affordable and convenient,” Dr. Tony Slonim, CEO of Renown Health, said in a statement. “We believe patients and their loved ones will have confidence in knowing that their Renown clinical team will be closely monitoring their health data and communicating with them regularly to deliver high quality, personalized care throughout their healing process.” Initially, the collaboration with BioIntelliSense will “focus on understanding the logistics of patient monitoring in the hospital and at home or remote sites,” according to the release. Renown Health will then work toward streamlining and operationalizing the clinical workflow, while scaling the program, to measure clinical improvement and the economic impact on patient care.
